Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Current Liabilities (2016 - 2025)

CV Sciences' Total Current Liabilities history spans 15 years, with the latest figure at $5.0 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 18.15% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 18.15% decrease, with the full-year FY2025 number at $5.0 million, down 18.15% from a year prior.
  • Total Current Liabilities hit $5.0 million in Q4 2025 for CV Sciences, up from $4.8 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CVSI hit a ceiling of $14.9 million in Q1 2021 and a floor of $4.8 million in Q3 2025.
  • Historically, Total Current Liabilities has averaged $9.0 million across 5 years, with a median of $6.1 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: rose 24.34% in 2021 and later tumbled 56.85% in 2023.
  • Tracing CVSI's Total Current Liabilities over 5 years: stood at $14.5 million in 2021, then decreased by 7.93% to $13.3 million in 2022, then crashed by 54.07% to $6.1 million in 2023, then decreased by 0.1% to $6.1 million in 2024, then dropped by 18.15% to $5.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for CVSI at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $5.7 million in Q2 2025.